Andreia Valente, PhD
CSO / CO-FOUNDER / BOARD MEMBER
Medicinal Chemist with expertise in anti-cancer early-stage Drug Discovery
Andreia is a researcher with expertise in Medicinal Chemistry and
anti-cancer early-stage Drug Discovery. She has a degree in
Technological Chemistry and a Masters in Biomedical Inorganic
Chemistry from Faculdade de Ciências, Universidade de Lisboa,
Portugal. She received her PhD from Université des Sciences et
Technologies de Lille 1 (France) in ‘Molécules et Matières
Condensées’. As a Fulbright awardee she spent 5 months at Rutgers
University (USA) in 2014/15 where she developed new toxicity and
speciation studies for metallodrugs screening. She has been
coordinator of several (inter)national research projects and has
participated in innovation European Programs (Innostars and Women
Leadership Program).
The thematic mobility that held Andreia’s research
path and the resulting competence synergy provided her experience
in wide-ranging key areas for the successful development of new
molecules/materials from the benchtop until the edge of having a
product with prospective commercial value.
M. Helena Garcia, PhD
CTO / CO-FOUNDER / BOARD MEMBER
Organometallic chemist with expertise in the design & synthesis of new anticancer metallodrugs
As Professor at Faculty of Sciences of the University of Lisbon,
Helena has built her recognized scientific career centered on the
design and synthesis of new organometallic compounds in view to
their technological applications. She was the coordinator of 20
national and international financed projects and co-authored over
150 publications in peer-reviewed international specialized
journals.
For the last fifteen years she has focused her
experience and expertise on the development of new anticancer
metallodrugs, being strongly motivated to contribute to the
solution of cancer related deaths, the second cause of death
worldwide. Particularly, she is interested on the cancers
considered unmet medical needs. In this frame she already
co-authored 4 inter- /national patents.
Having in view
to leverage the research and development from “the test tube to
the bed side” she has been very active on the participation in
European Programs focused on promoting entrepreneurship and
innovation on the domain of healthcare.
Francisco Rodrigues, MBA
CEO
General Manager
...
Technology Transfer Advisory Board
Jorge Maia Alves, PhD
TTO
President of the Commission for Innovation and Entrepreneurship, FCUL
Rita Tomé
TTO
Innovation and Entrepreneurship Manager at Tec Labs - Centro de Inovação, FCUL